PERSPECTA

News from every angle

← Back to headlines

China's AI Advances in Cancer Screening and Rare Disease Diagnosis

Chinese companies are making significant strides in personalized medicine, utilizing AI to boost cancer screening and rare disease diagnosis, with firms like MGI Tech and BGI Genomics leading in gene sequencing.

2 Mar, 05:00 — 2 Mar, 05:00
PostShare
Only 1 source covers this story